Literature DB >> 30874463

Impressionist portraits of mitotic exit: APC/C, K11-linked ubiquitin chains and Cezanne.

Thomas Bonacci1, Michael J Emanuele1,2.   

Abstract

The Anaphase-Promoting Complex/Cyclosome (APC/C) is an E3 ubiquitin ligase and a key regulator of cell cycle progression. By triggering the degradation of mitotic cyclins, APC/C controls cell cycle-dependent oscillations in cyclin-dependent kinase (CDK) activity. Thus, the dynamic activities of both APC/C and CDK sit at the core of the cell cycle oscillator. The APC/C controls a large number of substrates and is regulated through multiple mechanisms, including cofactor-dependent activation. These cofactors, Cdc20 and Cdh1, recognize substrates, while the specific E2 enzymes UBE2C/UbcH10 and UBE2S cooperate with APC/C to build K11-linked ubiquitin chains on substrates to target them for proteasomal degradation. However, whether deubiquitinating enzymes (DUBs) can antagonize APC/C substrate ubiquitination during mitosis has remained largely unknown. We recently demonstrated that Cezanne/OTUD7B is a cell cycle-regulated DUB that opposes the ubiquitination of APC/C substrates. Cezanne binds APC/C substrates, reverses their ubiquitination and protects them from degradation. Accordingly, Cezanne depletion accelerates APC/C substrate degradation, leading to errors in mitotic progression and formation of micronuclei. Moreover, Cezanne is significantly amplified and overexpressed in breast cancers. This suggests a potential role for APC/C antagonism in the pathogenesis of disease. APC/C contributes to chromosome segregation fidelity in mitosis raising the possibility that copy-number and expression changes in Cezanne observed in cancer contribute to the etiology of disease. Collectively, these observations identify a new player in cell cycle progression, define mechanisms of tempered APC/C substrate destruction and highlight the importance of this regulation in maintaining chromosome stability.

Entities:  

Keywords:  APC/C; Cezanne; Mitosis

Mesh:

Substances:

Year:  2019        PMID: 30874463      PMCID: PMC6464587          DOI: 10.1080/15384101.2019.1593646

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

1.  Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology.

Authors:  Donald S Kirkpatrick; Nathaniel A Hathaway; John Hanna; Suzanne Elsasser; John Rush; Daniel Finley; Randall W King; Steven P Gygi
Journal:  Nat Cell Biol       Date:  2006-06-25       Impact factor: 28.824

2.  A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B.

Authors:  R W King; J M Peters; S Tugendreich; M Rolfe; P Hieter; M W Kirschner
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

3.  The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis.

Authors:  V Sudakin; D Ganoth; A Dahan; H Heller; J Hershko; F C Luca; J V Ruderman; A Hershko
Journal:  Mol Biol Cell       Date:  1995-02       Impact factor: 4.138

Review 4.  Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression.

Authors:  Laura C Funk; Lauren M Zasadil; Beth A Weaver
Journal:  Dev Cell       Date:  2016-12-19       Impact factor: 12.270

5.  Cyclin is degraded by the ubiquitin pathway.

Authors:  M Glotzer; A W Murray; M W Kirschner
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

6.  USP7 small-molecule inhibitors interfere with ubiquitin binding.

Authors:  Lorna Kategaya; Paola Di Lello; Lionel Rougé; Richard Pastor; Kevin R Clark; Jason Drummond; Tracy Kleinheinz; Eva Lin; John-Paul Upton; Sumit Prakash; Johanna Heideker; Mark McCleland; Maria Stella Ritorto; Dario R Alessi; Matthias Trost; Travis W Bainbridge; Michael C M Kwok; Taylur P Ma; Zachary Stiffler; Bradley Brasher; Yinyan Tang; Priyadarshini Jaishankar; Brian R Hearn; Adam R Renslo; Michelle R Arkin; Frederick Cohen; Kebing Yu; Frank Peale; Florian Gnad; Matthew T Chang; Christiaan Klijn; Elizabeth Blackwood; Scott E Martin; William F Forrest; James A Ernst; Chudi Ndubaku; Xiaojing Wang; Maureen H Beresini; Vickie Tsui; Carsten Schwerdtfeger; Robert A Blake; Jeremy Murray; Till Maurer; Ingrid E Wertz
Journal:  Nature       Date:  2017-10-18       Impact factor: 49.962

7.  Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.

Authors:  Grace O Silva; Xiaping He; Joel S Parker; Michael L Gatza; Lisa A Carey; Jack P Hou; Stacy L Moulder; Paul K Marcom; Jian Ma; Jeffrey M Rosen; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2015-06-25       Impact factor: 4.872

8.  OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis.

Authors:  Tycho E T Mevissen; Manuela K Hospenthal; Paul P Geurink; Paul R Elliott; Masato Akutsu; Nadia Arnaudo; Reggy Ekkebus; Yogesh Kulathu; Tobias Wauer; Farid El Oualid; Stefan M V Freund; Huib Ovaa; David Komander
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

9.  Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth.

Authors:  Jinping Liu; Alex Kruswick; Hien Dang; Andy D Tran; So Mee Kwon; Xin Wei Wang; Philipp Oberdoerffer
Journal:  Nat Commun       Date:  2017-07-26       Impact factor: 14.919

10.  Mechanism of polyubiquitination by human anaphase-promoting complex: RING repurposing for ubiquitin chain assembly.

Authors:  Nicholas G Brown; Edmond R Watson; Florian Weissmann; Marc A Jarvis; Ryan VanderLinden; Christy R R Grace; Jeremiah J Frye; Renping Qiao; Prakash Dube; Georg Petzold; Shein Ei Cho; Omar Alsharif; Ju Bao; Iain F Davidson; Jie J Zheng; Amanda Nourse; Igor Kurinov; Jan-Michael Peters; Holger Stark; Brenda A Schulman
Journal:  Mol Cell       Date:  2014-10-09       Impact factor: 17.970

View more
  8 in total

1.  Dissenting degradation: Deubiquitinases in cell cycle and cancer.

Authors:  Thomas Bonacci; Michael J Emanuele
Journal:  Semin Cancer Biol       Date:  2020-03-20       Impact factor: 15.707

Review 2.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

3.  UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancer.

Authors:  Shengmeng Peng; Xu Chen; Chaoyun Huang; Chenwei Yang; Minyi Situ; Qianghua Zhou; Yihong Ling; Hao Huang; Ming Huang; Yangjie Zhang; Liang Cheng; Qiang Zhang; Zhenghui Guo; Yiming Lai; Jian Huang
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

Review 4.  Complex Cartography: Regulation of E2F Transcription Factors by Cyclin F and Ubiquitin.

Authors:  Michael J Emanuele; Taylor P Enrico; Ryan D Mouery; Danit Wasserman; Sapir Nachum; Amit Tzur
Journal:  Trends Cell Biol       Date:  2020-06-05       Impact factor: 20.808

5.  Identification of a novel ubiquitination related gene signature for patients with breast cancer.

Authors:  Yuan Zheng; Wenliang Lu; Bo Chen; Kankan Zhao
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

Review 6.  Causes and consequences of micronuclei.

Authors:  Ksenia Krupina; Alexander Goginashvili; Don W Cleveland
Journal:  Curr Opin Cell Biol       Date:  2021-02-18       Impact factor: 8.386

Review 7.  Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy.

Authors:  Keng Po Lai; Jian Chen; William Ka Fai Tse
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923

Review 8.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.